Načítá se...

SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib

Malignant melanoma is the most aggressive skin cancer and can only be cured if detected early. Unfortunately, later stages of the disease do not guarantee success due to the rapid rate of melanoma cell metastasis and their high resistance to applied therapies. The search for new molecular targets an...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Karwaciak, Iwona, Sałkowska, Anna, Karaś, Kaja, Sobalska-Kwapis, Marta, Walczak-Drzewiecka, Aurelia, Pułaski, Łukasz, Strapagiel, Dominik, Dastych, Jarosław, Ratajewski, Marcin
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2019
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562913/
https://ncbi.nlm.nih.gov/pubmed/31091806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050673
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!